Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis

BackgroundRecent clinical trials demonstrated longer survival in extended small cell lung cancer (SCLC) patients treated with immunotherapy in addition to chemotherapy. However, the magnitude of benefit is modest and the impact in real-world setting has to be fully established.MethodsWe collected cl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, Alberto Pavan, Loc Carlo Bao, Mattia De Nuzzo, Stefano Frega, Giulia Sartori, Alessandra Ferro, Giulia Pasello, Paolo Morandi, Giuseppe Aprile, Valentina Guarneri
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	small cell lung cancer immune-checkpoint inhibitors frail population long-term clinical benefit immune-related toxicity
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1353889/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!